drugset / Trial / NCT06284226
An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients
NaSingle-groupOpen-labelTreatment
Summary
An exploratory clinical study to evaluate the safety and efficacy of NK cells (combined with standard therapy) in the treatment of solid tumor patients
Timeline
- Start
- 2022-03-25
- Primary completion
- 2025-06-30
- Completion
- 2025-12-31
Outcome
Outcome not reported
Stopped: “The project is terminated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic NK | Cell therapy | — | — |
Indications
No indication recorded.